UniSa - IRIS Institutional Research Information System

PERSICO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.195
NA - Nord America 11.342
EU - Europa 4.217
SA - Sud America 993
Continente sconosciuto - Info sul continente non disponibili 392
AF - Africa 170
OC - Oceania 20
Totale 32.329
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.047
HK - Hong Kong 9.786
SG - Singapore 2.447
IT - Italia 1.607
CN - Cina 1.238
BR - Brasile 754
VN - Vietnam 706
UA - Ucraina 645
RU - Federazione Russa 431
DE - Germania 352
FR - Francia 251
IE - Irlanda 245
KR - Corea 231
FI - Finlandia 176
TR - Turchia 173
CA - Canada 146
SE - Svezia 132
BD - Bangladesh 116
GB - Regno Unito 113
IN - India 112
AR - Argentina 91
JP - Giappone 80
MX - Messico 70
ZA - Sudafrica 56
IQ - Iraq 49
NL - Olanda 41
ES - Italia 40
ID - Indonesia 40
EC - Ecuador 39
AT - Austria 33
PL - Polonia 32
CO - Colombia 31
VE - Venezuela 31
PK - Pakistan 28
DK - Danimarca 27
SA - Arabia Saudita 20
JM - Giamaica 18
MA - Marocco 18
MY - Malesia 18
EG - Egitto 17
UZ - Uzbekistan 17
PY - Paraguay 16
AU - Australia 15
CR - Costa Rica 15
TW - Taiwan 15
PH - Filippine 14
AZ - Azerbaigian 12
DZ - Algeria 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
JO - Giordania 11
LT - Lituania 11
RO - Romania 11
TN - Tunisia 11
GT - Guatemala 10
HN - Honduras 10
IL - Israele 10
KE - Kenya 10
PE - Perù 10
AL - Albania 9
CL - Cile 9
KZ - Kazakistan 8
PS - Palestinian Territory 8
GR - Grecia 7
OM - Oman 7
PT - Portogallo 7
SN - Senegal 7
BE - Belgio 6
CH - Svizzera 6
EU - Europa 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
NO - Norvegia 5
UG - Uganda 5
BH - Bahrain 4
CG - Congo 4
LB - Libano 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AO - Angola 3
BB - Barbados 3
BG - Bulgaria 3
BS - Bahamas 3
CI - Costa d'Avorio 3
ET - Etiopia 3
GY - Guiana 3
IR - Iran 3
LY - Libia 3
ME - Montenegro 3
MW - Malawi 3
NI - Nicaragua 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
Totale 31.900
Salva come PNG Salva come JPEG
Città #
Hong Kong 9.737
Ann Arbor 1.681
Singapore 1.277
San Jose 1.084
Chandler 840
Jacksonville 820
Princeton 723
Milan 608
Ashburn 574
Woodbridge 520
Dallas 462
Council Bluffs 422
Wilmington 366
Beijing 305
Houston 305
The Dalles 254
Dublin 238
Dong Ket 217
Lauterbourg 204
Andover 164
Ho Chi Minh City 163
Rome 157
Nanjing 147
Izmir 143
Los Angeles 136
Pellezzano 128
Boardman 123
Hanoi 109
Santa Clara 109
Moscow 95
New York 93
Munich 75
Naples 74
Memphis 69
São Paulo 68
Salerno 67
Tokyo 62
Hebei 55
Shenyang 54
Ottawa 47
Figino 46
Changsha 45
Fairfield 45
Columbus 43
Norwalk 43
Brooklyn 42
Nanchang 42
Montreal 40
Jiaxing 39
Turin 37
Frankfurt am Main 34
Düsseldorf 33
Phoenix 33
Redwood City 33
Denver 31
Mexico City 31
Nuremberg 31
Johannesburg 30
Stockholm 30
Tianjin 29
Chennai 28
Jinan 28
Washington 27
Chicago 26
London 26
Orem 26
Rio de Janeiro 26
Seattle 26
Turku 26
Mestre 25
Da Nang 24
Haiphong 24
Warsaw 24
Atlanta 23
Belo Horizonte 22
Boston 21
Guangzhou 21
Amsterdam 20
Dhaka 20
Falls Church 20
Dearborn 19
San Diego 19
Brasília 18
Curitiba 17
Helsinki 17
Baghdad 16
Manchester 16
San Francisco 15
Shanghai 15
Tashkent 15
Vienna 15
Caracas 14
Toronto 14
Cambridge 13
Guayaquil 13
Lappeenranta 13
Nürnberg 13
San José 13
Biên Hòa 12
Charlotte 12
Totale 24.294
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 967
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 774
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 769
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 716
Non Alcoholic Fatty Liver: Epidemiology and Natural History 633
Impact of telaprevir in HCV patients with cirrhosis and RVR: Real-life data from boceprevir or telaprevir based “triple therapy” experience in southern Italy 610
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 578
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? 519
Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects. 508
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 444
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. 416
Prospective validation of the CLIP score: a new prognostic system for patient with cirrhosis and hepatocellular carcinoma 405
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 400
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 381
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 373
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. 348
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 325
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 324
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 322
442 TNF-alpha and IL-10 genetic polymorphisms influence the natural history and the response to antiviral therapy in HCV related chronic hepatitis 314
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment 305
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma 299
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. 296
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 284
"Non alcoholic fatty liver disease and eNOS dysfunction in humans" 266
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 213
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 194
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 193
The diagnostic conundrum in non-alcoholic fatty liver disease 191
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 189
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 184
Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: association with autonomic neuropathy. 181
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 160
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 159
[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) 155
Coeliac disease and C virus-related chronic hepatitis: a non association 155
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 155
HIGH PREVALENCE OF HEPATITIS C (HCV) INFECTION AND FAVORABLE PROGNOSIS IN PRIMARY HEPATIC LYMPHOMA (PHL) 153
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 152
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach]. 151
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 151
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 148
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. 147
Alcoholic Liver Disease and Hepatitis C Chronic Infection 146
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 145
Epidemiology and Natural History of Alcoholic Liver Disease 144
Adiponectin in hepatology 144
Pharmacotherapy of alcoholic liver disease in clinical practice 143
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 136
A controlled trial on treatment of patients with HCV infection and abnormal liver function tests with or without liver biopsy 135
A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection. 134
Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). 134
[Diabetic neuropathies. IV. Autonomous neuropathy. Peripheral sympathetic innervation and the cardiovascular system]. 134
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. 134
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 134
Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. 133
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analogues 133
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. 131
Antiviral therapy: Why does it fail in HCV-related chronic hepatitis? 131
Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy 131
154 LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY 130
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 129
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. 127
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 127
Risk factors for hospital readmission of elderly patients. 126
A randomised controlled trial on pegylated interferon alfa-2a (40kd)(Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV 124
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea 124
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 124
Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients 123
93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study 123
Electrophysiological evidence for Na+-coupled bicarbonate transport in cultured rat hepatocytes 122
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025) 122
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 121
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? 120
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 120
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis 119
Effect of different doses of S-adenosyl-L-methionine (SAMe) on nicotinic acid-induced hyperbilirubinaemia in Gilbert's syndrome. 118
Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. 117
478 Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study 117
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 116
Steatosis as a co-factor in chronic liver diseases 115
Na+-H+ exchange activity in rat hepatocytes: Role in regulation of intracellular pH 114
Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of Southern Italy in the province of Salerno 114
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system]. 113
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. 113
HCV antiviral therapy in injection drug users: difficult to treat or easy to cure? 113
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 113
Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells 113
Viral hepatitis: Milestones, unresolved issues, and future goals 113
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C 111
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy 110
Metabolic associated steatotic liver disease in renal transplant recipients: a retrospective cohort study 109
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 109
Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome: the role of reduced affinity of the plasma membrane carrier of organic anions. 109
Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. 108
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment 108
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 107
Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: Results of a prospective multicentric study 107
Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans. 106
The clinical significance of occult HBV infection in acute delta virus hepatitis in a case of immunosuppressive therapy for non-Hodgkin lymphomas. 106
Totale 21.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.239 0 0 8 6 26 24 34 58 193 169 156 565
2022/20232.009 207 118 63 237 291 430 12 185 301 5 108 52
2023/2024890 82 120 69 32 71 140 32 44 8 34 51 207
2024/20252.756 73 46 56 118 152 290 434 323 486 170 291 317
2025/202618.202 1.663 4.630 4.623 550 1.186 593 1.750 346 548 911 302 1.100
2026/2027764 360 323 81 0 0 0 0 0 0 0 0 0
Totale 32.329